As of tomorrow, individual genetic risk tests are officially exempt from requiring 501(k) premarket approval, provided the company offering the test has gone through a one-time premarket review of its testing apparatus and at least one test.
from MobiHealthNews https://ift.tt/2sIgLUK
June 05, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Itamar Medical launches SleePath to track sleep apnea in AFib patientsSleep management company Itamar Medical has just launched SleePath, a digital sleep apnea management tool that helps cardiologists monitor patients with atrial fibrillation. The platform allows doctors to check their patients… Read More
Fitbit announces new partnerships, focus on chronic disease management, overall healthFitbit has announced a slew of new digital health apps and clock faces that were born out of partnerships with major players such as Dexcom, Humana, and Walgreens. The apps, which were built on Fitbit’s software development k… Read More
Digital health news briefs for 5/7/16Charlotte, North Carolina-based PeraHealth has received FDA clearance for its latest product, PeraTrend, a predictive clinical surveillance tool. from MobiHealthNews https://ift.tt/2I0v6Gz … Read More
Vida Health revamps platform, offers targeted programs for diabetes, behavioral healthToday at HLTH: The Future of Healthcare Conference, San Francisco-based Vida Health announced an update to its digital health coaching platform for enterprises that is specifically designed to target comorbidities, as well as… Read More
Lyra Health raises $45 million to connect patients to behavioral health careDigital behavioral health company Lyra Health announced today that it has secured a $45 million Series B round of funding. Participants in the round included new investors Tenaya Capital, Glynn Capital, Crown Ventures, and Ca… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment